CRISPR Therapeutics AG (NASDAQ:CRSP) Position Raised by NewEdge Advisors LLC
NewEdge Advisors LLC grew its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 28.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 7,420 shares of the company’s stock after purchasing an additional 1,622 shares during the quarter. NewEdge Advisors LLC’s […]
